{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:50:33Z","timestamp":1769809833747,"version":"3.49.0"},"reference-count":33,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.16.04038","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:43:58Z","timestamp":1769773438000},"source":"Crossref","is-referenced-by-count":0,"title":["Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study"],"prefix":"10.7189","volume":"16","author":[{"given":"Jakob Kronkvist","family":"Hoe","sequence":"first","affiliation":[{"name":"Bispebjerg and Frederiksberg Hospital, Copenhagen Phase IV unit (Phase4CPH) at department of Clinical Pharmacology and Centre of Clinical Research and Prevention, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Blond","sequence":"additional","affiliation":[{"name":"Danish Medicines Council, Secretariat for Chronic Diseases, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Jimenez-Solem","sequence":"additional","affiliation":[{"name":"Bispebjerg and Frederiksberg Hospital, Copenhagen Phase IV unit (Phase4CPH) at department of Clinical Pharmacology and Centre of Clinical Research and Prevention, Copenhagen, Denmark"},{"name":"Bispebjerg and Frederiksberg Hospital, Department of Clinical Pharmacology, Copenhagen, Denmark"},{"name":"University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Berry","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Chiang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel Z\u00f6llner","family":"Ankarfeldt","sequence":"additional","affiliation":[{"name":"Bispebjerg and Frederiksberg Hospital, Copenhagen Phase IV unit (Phase4CPH) at department of Clinical Pharmacology and Centre of Clinical Research and Prevention, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[{"name":"Bispebjerg and Frederiksberg Hospital, Copenhagen Phase IV unit (Phase4CPH) at department of Clinical Pharmacology and Centre of Clinical Research and Prevention, Copenhagen, Denmark"},{"name":"University of Copenhagen, Department of Public Health section of Biostatistics, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4223","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"key-10.7189\/jogh.16.04038-202601301102-R1","doi-asserted-by":"publisher","first-page":"X241228053","DOI":"10.1177\/2632010X241228053","article-title":"The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts.","volume":"17","author":"Roknuzzaman","year":"2024","journal-title":"Clin Pathol"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R2","unstructured":"Epidemiological update: COVID-19 transmission in the EU\/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023. 7 September 2023. Available: https:\/\/www.ecdc.europa.eu\/en\/news-events\/epidemiological-update-covid-19-transmission-eueea-sars-cov-2-variants-and-public. Accessed: 16 June 2024."},{"key":"key-10.7189\/jogh.16.04038-202601301102-R3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/medicina59081393","article-title":"Comorbidities of COVID-19 Patients.","volume":"59","author":"Silaghi-Dumitrescu","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R4","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/s41598-023-29517-9","article-title":"Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro.","volume":"13","author":"Radoshitzky","year":"2023","journal-title":"Sci Rep"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R5","doi-asserted-by":"crossref","unstructured":"FDA\u2019a Office of the Commissioner. FDA Approves First Treatment for COVID-19. FDA. 22 October 2020. Available: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19. Accessed: 16 June 2024.","DOI":"10.1002\/cpu.30542"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R6","unstructured":"Fischer. CP. DSI guidelines. Available: https:\/\/www.infmed.dk\/guidelines. Accessed: 16 June 2024."},{"key":"key-10.7189\/jogh.16.04038-202601301102-R7","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19.","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Final Report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R9","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1503\/cmaj.211698","article-title":"Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.","volume":"194","author":"Ali","year":"2022","journal-title":"CMAJ"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(21)00485-0","article-title":"Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.","volume":"22","author":"Ader","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R13","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.2147\/JIR.S378347","article-title":"Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19.","volume":"15","author":"Aksak-W\u0105s","year":"2022","journal-title":"J Inflamm Res"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11096-023-01554-4","article-title":"Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System.","volume":"45","author":"Li","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R15","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/jcm11113132","article-title":"Remdesivir in the Treatment of COVID-19: A Propensity Score-Matched Analysis from a Public Hospital in New York City Assessing Renal and Hepatic Safety.","volume":"11","author":"Lim","year":"2022","journal-title":"J Clin Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R16","doi-asserted-by":"publisher","first-page":"05031","DOI":"10.7189\/jogh.12.05031","article-title":"Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.","volume":"12","author":"Polivka","year":"2022","journal-title":"J Glob Health"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R17","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.3390\/jcm11216545","article-title":"Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).","volume":"11","author":"Zerbit","year":"2022","journal-title":"J Clin Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R18","doi-asserted-by":"publisher","first-page":"e28660","DOI":"10.1002\/jmv.28660","article-title":"Risk of hospitalization and sequelae in patients with COVID-19 treated with 3-day early remdesivir vs. controls in the vaccine and Omicron era: A real-life cohort study.","volume":"95","author":"Mazzitelli","year":"2023","journal-title":"J Med Virol"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R19","doi-asserted-by":"publisher","first-page":"e28168","DOI":"10.1002\/jmv.28168","article-title":"Effectiveness of remdesivir with corticosteroids for COVID-19 patients in intensive care unit: A hospital-based observational study.","volume":"95","author":"Hanafusa","year":"2023","journal-title":"J Med Virol"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R20","doi-asserted-by":"publisher","first-page":"e2114741","DOI":"10.1001\/jamanetworkopen.2021.14741","article-title":"Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.","volume":"4","author":"Ohl","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5005\/jp-journals-10071-24189","article-title":"Effect of Remdesivir Administration on Occurrence of Major Adverse Cardiac Events in Critically Ill COVID-19 Pneumonia: A Retrospective Observational Study.","volume":"26","author":"Panda","year":"2022","journal-title":"Indian J Crit Care Med"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s15010-023-01994-0","article-title":"Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.","volume":"51","author":"Pilgram","year":"2023","journal-title":"Infection"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R23","doi-asserted-by":"publisher","first-page":"ofac502","DOI":"10.1093\/ofid\/ofac502","article-title":"Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.","volume":"9","author":"Rajme-L\u00f3pez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12884-023-05405-y","article-title":"Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID-19?","volume":"23","author":"Tavakoli","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijid.2022.02.039","article-title":"Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.","volume":"118","author":"Tsuzuki","year":"2022","journal-title":"Int J Infect Dis"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R26","doi-asserted-by":"publisher","first-page":"e0279765","DOI":"10.1371\/journal.pone.0279765","article-title":"Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.","volume":"18","author":"Seethapathy","year":"2023","journal-title":"PLoS One"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R27","doi-asserted-by":"publisher","first-page":"e2244505","DOI":"10.1001\/jamanetworkopen.2022.44505","article-title":"Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.","volume":"5","author":"Chokkalingam","year":"2022","journal-title":"JAMA Netw Open"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R28","first-page":"1","article-title":"Denmark: Health System Review.","volume":"26","author":"Birk","year":"2024","journal-title":"Health Syst Transit"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.","volume":"399","author":"WHO Solidarity Trial Consortium","year":"2022","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R30","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1093\/jac\/dkac256","article-title":"Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge.","volume":"77","author":"Piccicacco","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"key-10.7189\/jogh.16.04038-202601301102-R31","unstructured":"European Medicines Agency. Veklury product information. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/veklury-epar-product-information_en.pdf. Accessed: 14 March 2025."},{"key":"key-10.7189\/jogh.16.04038-202601301102-R32","unstructured":"The Danish Health Authority. Brug af l\u00e6gemidler til behandling og forebyggelse af COVID-19. Available: https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2023\/Corona\/NKA\/NKA-Covid-19.ashx. Accessed: 14 March 2025."},{"key":"key-10.7189\/jogh.16.04038-202601301102-R33","unstructured":"Statens Serum Institut (SSI). Historical COVID-19 assessment. Available: https:\/\/www.ssi.dk\/sygdomme-beredskab-og-forskning\/sygdomsovervaagning\/c\/historiske-covid-19-opgoerelser. Accessed: 31 January 2025."}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:43:59Z","timestamp":1769773439000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7189\/jogh.16.04038","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"04038"}}